Download PDF
Thromb Haemost 1966; 15(03/04): 591-602
DOI: 10.1055/s-0038-1649461
Übersichten — Reviews — Revues Générales
Schattauer GmbH

The Basis of the Cascade Hypothesis of Blood Clotting

R. G Macfarlane
Blood Coagulation Research Unit, Churchill Hospital, Oxford
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Biggs R, Macfarlane R. G, Denson K. W. E, Ash B. J. Thrombin and the interaction of Factors VIII and IX. Brit. J. Haemat 11: 276 1965;
    CrossrefPubMedGoogle Scholar
  • 2 Davie E. W, Ratnoff O. D. Waterfall sequence for intrinsic blood clotting. Science 145: 1310 1964;
    CrossrefPubMedGoogle Scholar
  • 3 Esnouf M. P, Williams W. J. The Isolation and Purification of a B ovine - Plasma protein which is a substrate for the coagulant factor of Russell’s viper venom. Biochem. J 84: 62 1962;
    CrossrefPubMedGoogle Scholar
  • 4 Ferguson J. H, Ennis E. G. W. Enzymes and blood clotting. II. Autoprothrombin C, Russell’s viper venom (Stypvin) and Trypsin. Thrombos. Diathes. haemorrh. (Stuttg) 09: 62 1963;
    PubMedGoogle Scholar
  • 5 Kingdon H. S, Davie E. W, Ratnoff O. D. The reaction between activated plasma thromboplastin antecedent and di-isoprophyl phospho fluoridate. Biochem 03: 166 1964;
    CrossrefPubMedGoogle Scholar
  • 6 Kline D. L. Blood coagulation : reactions leading to prothrombin activation. Ann. Rev. Physiol 27: 285 1965;
    CrossrefPubMedGoogle Scholar
  • 7 Macfarlane R. G. The coagulant action of Russell’s viper venom : the use of antivenom in defining its reaction with a serum factor. Brit. J. Haemat 07: 496 1961;
    CrossrefPubMedGoogle Scholar
  • 8 Macfarlane R. G. Observations on the interaction of Factors VIII, IX, and X. Thrombos. Diathes. haemorrh. (Stuttg). 09 (Suppl. 02) 221 1963;
    PubMedGoogle Scholar
  • 9 Macfarlane R. G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature (Lond.) 202: 498 1964;
    CrossrefPubMedGoogle Scholar
  • 10 Macfarlane R. G. “A clotting scheme for 1964” Genetics and the Interaction of blood clotting factors. Schattauer; Stuttgart: 1965
    Google Scholar
  • 11 Macfarlane R. G, Ash B. J. The activation and consumption of Factor X in recalcified plasma. The effect of added Factor VIII and Russell’s viper venom. Brit. J. Haemat 10: 217 1964;
    CrossrefPubMedGoogle Scholar
  • 12 Macfarlane R. G, Biggs R, Ash B. J, Denson K. W. E. The interaction of Factors VIII and IX. Brit. J. Haemat 10: 530 1964;
    CrossrefPubMedGoogle Scholar
  • 13 Marr J, Barboriak J. J, Johnson S. A. The relationship of appearance of adenosine diphosphate, fibrin formation and platelet aggregation in the haemostatic plug in vivo. Nature (Lond.) 205: 259 1965;
    CrossrefPubMedGoogle Scholar
  • 14 Milstone J. H. Thrombokinase as prime activator of prothrombin: historical perspectives and present status. Fed. Proc 23: 742 1964;
    PubMedGoogle Scholar
  • 15 Milstone J. H. Blood coagulation — a basic science review. Conn. Med 28: 653 1964;
    PubMedGoogle Scholar
  • 16 Nemerson Y, Spaet T. H. The activation of Factor X by extracts of rabbit brain. Blood 23: 657 1964;
    PubMedGoogle Scholar
  • 17 Pechet L, Alexander B. Activation of prothrombin, Factors VII and X by proteolytic pathway. Trypsin and Papain. Fed. Proc. 19: 01: 64 1960;
    PubMedGoogle Scholar
  • 18 Purcell G. M, Barnhart M. I. Prothrombin activation with cathepsin C. Biochim. biophys. Acta. (Amst.) 78: 800 1963;
    CrossrefPubMedGoogle Scholar
  • 19 Ratnoff O. D, Davie E. W, Mallett D. L. Studies on the action of Hageman factor; evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J. clin. Invest 40: 803 1961;
    CrossrefPubMedGoogle Scholar
  • 20 Ratnoff O. D, Davie E. W. The activation of Christmas factor (Factor IX) by activated plasma thromboplastin antecedent (activated Factor XI). Biochemistry 01: 677 1962;
    CrossrefPubMedGoogle Scholar
  • 21 Ratnoff O. D, Davie E. W. The purification of activated Hageman factor (activated Factor XII). Biochemistry 01: 967-75 1962;
    CrossrefPubMedGoogle Scholar
  • 22 Rapaport S. I, Schiffman S, Patch M. J, Ames S. B. The importance of activation of antihaemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood 21: 221 1963;
    PubMedGoogle Scholar
  • 23 Schiffman S, Rapaport S. I, Patch M. J. The identification and synthesis of activated ▪ plasma thromboplastin component (PTC). Blood 22: 733 1963;
    PubMedGoogle Scholar
  • 24 Seegers W. H. Prothrombin. Harvard University Press; 1962
    Google Scholar
  • 25 Seegers W. H. Basic enzymology of blood coagulation. Thrombos. Diathes. haemorrh. (Stuttg) 14: 213 1965;
    PubMedGoogle Scholar
  • 26 Shulman N. R. S, Hearon J. Z. Kinetics of conversion of prothrombin to thrombin by biological activators. J. Biol. Chem 238: 155-164 1963;
    PubMedGoogle Scholar
  • 27 Spaet T. H, Cintron J. Pathways to blood coagulation product I formation. Blood 21: 745 1963;
    PubMedGoogle Scholar
  • 28 Webster’s Third International Dictionary. G. & C. Merriam Co; Springfield, Mass: 1961
    Google Scholar
  • 29 Williams W. J, Esnouf M. P. The fractionation of Russell’s viper (Vipera russellii) venom with special reference to the coagulant protein. Biochem. J 84: 52 1962;
    CrossrefPubMedGoogle Scholar